期刊文献+

临床药师参与化疗后骨髓抑制的药物治疗1例 被引量:2

A case of clinical pharmacist participating in the treatment of myelosuppression after chemotherapy
原文传递
导出
摘要 通过1例卵巢癌化疗后粒细胞缺乏使用粒细胞集落刺激因子(G-CSF)的病例,就G-CSF的预防及治疗性使用、用药时机及用药疗程进行分析。G-CSF的规范性使用主要包括4个方面:G-CSF与化疗药物至少应有24 h的时间窗;根据化疗方案及患者情况决定G-CSF的预防或治疗;化疗过程中出现粒细胞缺乏,需在后续化疗时预防性使用G-CSF;使用G-CSF 1~2 d后出现的中性粒细胞峰值是骨髓增生引起,应继续用药至出现第2个峰值。G-CSF的规范性使用对于保证化疗进行发挥着重要作用,临床药师应辅助医师把控G-CSF的合理性应用,从而保证肿瘤患者化疗方案的顺利进行。
作者 李瑞瑞 赵晋 栗芳 LI Rui-rui;ZHAO Jin;LI Fang(Department of Pharmacy,Beijing Shijitan Hospital Affiliated to Capital Medical University,Beijing 100038,China;Department of Pharmacy,Aviation General Hospital of China Medical University,Beijing 100012,China;Department of Gynaecology,Beijing Shijitan Hospital Affiliated to Capital Medical University,Beijing 100038,China;Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use,Beijing 100038,China)
出处 《临床药物治疗杂志》 2020年第11期72-74,共3页 Clinical Medication Journal
基金 临床合理用药评价北京市重点实验室开放研究课题(项目编号:2019-KF08)。
  • 相关文献

参考文献3

二级参考文献26

  • 1石远凯,周际昌,冯奉仪,曾万勇,李青,何小慧,张弘刚,张湘茹,周立强.基因重组人粒细胞集落刺激因子对肿瘤化疗所致白细胞减少的临床疗效观察[J].中华肿瘤杂志,1994,16(3):207-210. 被引量:35
  • 2汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 3石远凯,何小慧,杨晟,王华庆,江泽飞,朱允中,克晓燕,张阳,刘云鹏,张伟京,王昭,石庆芝,谢晓冬,张贺龙,王杰军,罗德云,郑青山,孙瑞元.聚乙二醇化重组人粒细胞集落刺激因子预防化疗后中性粒细胞减少症的多中心随机对照Ⅱ期临床研究[J].中华医学杂志,2006,86(48):3414-3419. 被引量:43
  • 4FreifeldAG, BowEJ, SepkowitzKA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 52(4):427-431. doi: 10.1093/cid/ciq147.
  • 5AverbuchD, OraschC, CordonnierC, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia [J]. Haematologica, 2013, 98(12):1826-1835. doi: 10.3324/haematol.2013.091025.
  • 6AverbuchD, CordonnierC, LivermoreDM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)[J]. Haematologica, 2013, 98(12):1836-1847. doi: 10.3324/haematol.2013.091330.
  • 7ZhaiW, ZhangX, WeiJ, et al. A Prospective Observational Study of Antibiotic Therapy in Febrile Neutropenia Patients with Hematological Malignances from Multiple centers in Northeast China [J]. Int J Infect Dis, 2015, 37:97-103. doi: 10.1016/j.ijid.2015.04.015.
  • 8KernWV, MarchettiO, DrgonaL, et al. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV [J]. J Clin Oncol, 2013, 31(9):1149-1156. doi: 10.1200/JCO.2012.45.8109.
  • 9WunderinkRG, RelloJ, CammarataSK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia[J]. Chest, 2003, 124(5):1789-1797.
  • 10ChaftariAM, HachemR, MulanovichV, et al. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients [J]. Int J Antimicrob Agents, 2010, 36(2):182-186. doi: 10.1016/j.ijantimicag.2010.03.015.

共引文献390

同被引文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部